Supplemental iodide for preterm infants and developmental outcomes at 2 years: an RCT by Williams, F, Ogston, S, Hume, R, Watson, J, Stanbury, K, Willatts, P, Boelen, A, Juszczak, E, Brocklehurst, P

RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. by Brenna, J, Burdge, G, Crawford, M, Clayton, P, Cunnane, S, Gow, R, Hibbeln, JR, Sinclair, A, Stein, J, Willatts, P